“EXPOSURE” (EUPAS19085) is an observational study describing the characteristics, treatment patterns, and outcomes of patients with pulmonary arterial hypertension initiating a new specific therapy in Europe/Canada.
In total, 1.944 patients with follow-up information were included. Most study patients were female with WHO functional class II/III symptoms and idiopathic or connective tissue disorder-associated pulmonary arterial hypertension.
The findings of the EXPOSURE study were published on January 13, 2024, in “Advances in Therapy”.
The article is open access and can be consulted at this link on the “Advances in Therapy” web page.
Citation
Audrey Muller, Pilar Escribano-Subias, Catarina C. Fernandes, Martina Fontana, Tobias J. Lange, Stefan Söderberg & Sean Gaine: Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE. Adv Ther (2024). https://doi.org/10.1007/s12325-023-02730-8
